金 一,姜大庆,马 特.新辅助内分泌治疗后腋窝转移淋巴结中Ki-67蛋白表达对绝经后乳腺癌预后的影响[J].肿瘤学杂志,2016,22(12):1042-1047.
新辅助内分泌治疗后腋窝转移淋巴结中Ki-67蛋白表达对绝经后乳腺癌预后的影响
Association Between Expression of Ki-67 in Axillary Lymph Nodes and Prognosis of Postmenopausal Breast Cancer Patients After Neoadjuvant Endocrine Therapy
投稿时间:2016-04-19  
DOI:10.11735/j.issn.1671-170X.2016.12.B012
中文关键词:  新辅助内分泌治疗  腋窝淋巴结  Ki-67  预后  乳腺肿瘤
英文关键词:neoadjuvant endocrine therapy  axillary lymph nodes  Ki-67  prognosis  breast neoplasms
基金项目:国家自然科学基金项目(81572831)
作者单位
金 一 中国医科大学肿瘤医院辽宁省肿瘤医院 
姜大庆 中国医科大学肿瘤医院辽宁省肿瘤医院 
马 特 中国医科大学肿瘤医院辽宁省肿瘤医院 
摘要点击次数: 2096
全文下载次数: 736
中文摘要:
      摘 要:[目的] 探讨乳腺癌新辅助内分泌治疗后腋窝转移淋巴结中Ki-67蛋白的表达和患者预后的关系。[方法] 回顾性分析108例新辅助内分泌治疗腋窝转移淋巴结乳腺癌患者的临床和病理资料。结果 108例患者中,术后淋巴结Ki-67蛋白>10%者71例,Ki-67≤10%者37例。全组中位随访40个月,其中Ki-67≤10%组和Ki-67>10%组无病生存率分别为83.8%,54.9%,差异有统计学意义(P=0.004);总生存率分别为91.9%和71.8%,差异有统计学意义(P=0.019)。COX多因素分析的结果显示,术后腋窝淋巴结Ki-67蛋白表达的状态是影响患者无病生存和总生存的主要因素(RR=0.300,95%CI为0.125~0.718,P=0.007;RR=0.260,95%CI为0.077~0.876,P=0.030)。[结论] 新辅助内分泌治疗后腋窝淋巴结Ki-67蛋白表达的高低是预测乳腺癌患者预后的有效指标。
英文摘要:
      Abstract:[Objective] To investigate the association between expression of Ki-67 in axillary lymph nodes and prognosis in postmenopausal breast cancer patients after neoadjuvant endocrine therapy. [Methods] The clinical and pathological data of 108 postmenopausal breasts cancer patients who underwent neoadjuvant endocrine therapy were analyzed retrospectively. [Results] The median follow up time was 40 months. Among 108 patients the expression of Ki-67 in axillary lymph nodes was >10% in 71 cases and expression of Ki-67 was ≤10% in 37 cases. The disease free survival(DFS) in the two groups was 54.9% and 83.8%(P=0.004),the overall survival(OS) was 71.8% and 91.9%(P=0.019),respectively. The multivariate analysis indicated that the expression of Ki-67 in axillary lymph nodes was an independent prognostic factor for DFS and OS (RR=0.300,95%CI:0.125~0.718,P=0.007;RR=0.260,95%CI:0.077~0.876,P=0.030).[Conclusion] The expression of Ki-67 in axillary lymph nodes is an effective indicator for predicting the prognosis of postmenopausal breast cancer patients after neoadjuvant endocrine therapy.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器